The ROE as of September 2024 (TTM) for Cingulate Inc. (CING) is 11.47%

According to Cingulate Inc.’s latest financial reports and current stock price. The company's current ROE is 11.47%. This represents a change of 650.85% compared to the average of 1.53% of the last 4 quarters.

Cingulate Inc. (CING) Historical ROE (quarterly & annually)

How has CING ROE performed in the past?

The mean historical ROE of Cingulate Inc. over the last ten years is -430.63%. The current 11.47% ROE has changed -2763.84% with respect to the historical average. Over the past ten years (40 quarters), CING's ROE was at its highest in in the September 2023 quarter at 6.21%. The ROE was at its lowest in in the March 2023 quarter at -194883.42%.

Cingulate Inc. (CING) ROE by Quarter and Year

Discovering the peaks and valleys of Cingulate Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cingulate Inc. (CING) Average ROE

How has CING ROE performed in the past?

The current ROE of Cingulate Inc. (CING) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cingulate Inc. (CING) ROE vs. Peers

How is CING’s ROE compared to its peers?

Cingulate Inc.’s ROE is less than SAB Biotherapeutics, Inc. (0%), greater than Senti Biosciences, Inc. (-94.04%), greater than Bellicum Pharmaceuticals, Inc. (-91.09%), less than Hillstream BioPharma, Inc. (153.34%), greater than Aerovate Therapeutics, Inc. (-47249.59%), greater than Adagene Inc. (-83.65%), greater than Acrivon Therapeutics, Inc. Common Stock (-63.48%), greater than Rezolute, Inc. (-47.31%), greater than AN2 Therapeutics, Inc. (-60.90%), greater than Genelux Corporation (-54.72%), greater than Comera Life Sciences Holdings, Inc. (-110.28%), less than Dyadic International, Inc. (1.54%), greater than Monopar Therapeutics Inc. (-145.95%), greater than Miromatrix Medical Inc. (-110.60%), greater than Inhibikase Therapeutics, Inc. (-119.21%), greater than PMV Pharmaceuticals, Inc. (-194.17%), greater than Anebulo Pharmaceuticals, Inc. (-21.96%), greater than null (-122.97%),

Build a custom stock screener for Cingulate Inc. (CING) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cingulate Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cingulate Inc. (CING) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cingulate Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.